Bain Capital Life Sciences Fund III, L.P.
Related Filers (13)
- Bain Capital Life Sciences Investors, LLC (3)
- Bain Capital Life Sciences III General Partner, LLC (3)
- Bain Capital Life Sciences Opportunities III GP, LLC (2)
- Bain Capital Life Sciences Opportunities III, LP (2)
- Kyverna Therapeutics, Inc. (2)
- BCLS II Investco, LP (1)
- Bain Capital Life Sciences Investors II, LLC (1)
- Bain Capital Life Sciences Fund II, L.P. (1)
- BCLS II Investco (GP), LLC (1)
- BCLS Fund III Investments GP, LLC (1)
- BCIP Life Sciences Associates, LP (1)
- BCLS Fund III Investments, LP (1)
- NewAmsterdam Pharma Co N.V. (1)
- Show More ...
Other (6)
13F-NT
Tuesday, 2/13/2024
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 11/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 8/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Monday, 5/15/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
13F-NT
Tuesday, 2/14/2023
Initial Quarterly Form 13F Notice Report filed by institutional managers
D
Tuesday, 8/3/2021
Exempt (Private) Offering
Ownership (3)
4
Wednesday, 2/14/2024
Kyverna Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/7/2024
Kyverna Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Friday, 12/29/2023
NewAmsterdam Pharma Co N.V.: Initial statement of beneficial ownership of securities